knowledge -WSS

knowledge

author：focus 2025-10-02 19:38:47 - browse：47

Blood corpuscles in clot — Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success. David Gregory & Debbie Marshall/Wellcome Images

Vascular device maker Inari Medical announced plans to buy LimFlow, a company selling a last-line therapy to save legs with blocked blood flow, on Wednesday. Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success.

LimFlow recently snagged Food and Drug Administration approval for its surgical system that uses a stent to connect a blocked artery to an open vein, thus allowing blood to flow through and heal injuries. The tool is meant only for patients with a severe form of peripheral artery disease, and who have already tried more conservative options.

Dan Rose, CEO of LimFlow, previously told STAT that his mission is to fight the amputation epidemic in the United States, which disproportionately impacts Black patients. Experts cautioned to STAT that expanding screenings to catch the disease early is still the most important measure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Judge rejects Trump's request to move Stormy Daniels hush

WSS

A deep dive into Applied Therapeutics’ data, and questions on Cassava

In his State of the Union, Biden takes clear aim at 'Big Pharma'

I learned firsthand about improving diversity in clinical trials

Precocious puberty in girls comes with mental health risks

The Readout: Amylyx, Alumis, and Lundbeck drug updates

IVF, abortion rights issues kick off Biden’s State of the Union

explore

knowledge

explore

The high cost of giving birth even with insurance

UnitedHealth quietly bought dozens of outpatient centers

Cancer drug shortages should be causing more outrage

CDC marks new Covid

Activists slam private health insurers over coverage restrictions

Just how do doctors, lawmakers, and the public define abortion?

Medical records are filled with copy

Driven by the pandemic, applicants flood public health schools

23andMe had bad news about my health. I wish a person had delivered it

Amylyx ALS drug failure raises questions and concerns

focus

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

I learned firsthand about improving diversity in clinical trials

Mass General totes up its waste in a move to tackle climate change

What it’s like to watch children die of measles

Ending racial health disparities hinges on penalties, political will

focus

Wikipedia

Wikipedia

Wikipedia